Caxton Associates (New York)’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Caxton Associates (New York)’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,559	Closed	-$215K	–	646
2022 Q3	$215K	Buy	+4,559	New	+$294K	0.03%	387
2017 Q4	–	Sell	-5,100	Closed	-$267K	–	565
2017 Q3	$267K	Hold	5,100	–	–	0.01%	450
2017 Q2	$298K	Buy	+5,100	New	+$265K	0.01%	443

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Caxton Associates (New York)'s SYNH Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 4,559 shares — an estimated $215K sold.

Caxton Associates (New York) first reported a position in SYNH in Q2 2017 and held it in 3 quarters. The position peaked at $298K in Q2 2017. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Caxton Associates (New York) reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Caxton Associates (New York) sold 4,559 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $215K.
Caxton Associates (New York) first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 3 quarters.
Caxton Associates (New York)'s Syneos Health, Inc. Class A Common Stock position peaked at $298K in Q2 2017.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.